Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 1003-1006

  Conway, David J ^a   Holland, Martin J ^a   Bailey, Robin L ^a,b   Campbell, Alison E ^a   Mahdi, Olaimatu S M ^b   Jennings, Richard ^a   Mbena, Ephraim ^a   Mabey, David C W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHLAMYDIA TRACHOMATIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; INFLAMMATION; LACRIMAL FLUID LEVEL; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; SCAR FORMATION; SCHOOL CHILD; STATISTICAL ANALYSIS; TRACHOMA;

EID: 0031030701     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.1003-1006.1997     Document Type: Article

References (37)

1. Abraham, L. J., M. A. H. French, and R. L. Dawkins. 1993. Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-alpha. Clin. Exp. Immunol. 92:14-18.
2. Bailey, R. L., T. J. Hampton, L. J. Haves, M. E. Ward, H. C. Whittle, and D. C. W. Mabey. 1994. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. J. Infect. Dis. 170: 709-712.
3. Bailey, R. L., M. J. Holland, H. C. Whittle, and D. C. W. Mabey. 1995. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect. Immun. 63:389-392.
4. Bobo, L., N. Novak, H. Mkocha, S. Vitale, S. West, and T. C. Quinn. 1996. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect. Immun. 64:3273-3279.
5. Border, W. A., and N. A. Noble. 1994. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1286-1292.
6. Bouma, G., B. Xia, J. B. A. Crusius, G. Bioque, I. Koutroubakis, B. M. E. Von Blomberg, S. G. M. Meuwissen, and A. S. Pena. 1996. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103:391-396.
7. Brinkman, B. M. N., D. Zuijdgeest, E. L. Kaijzel, F. C. Breeveld, and C. L. Verweij. 1995. Functional consequences of the TNFα -308 polymorphism on gene expression. Immunology 86(Suppl. 1):75. (Abstract).
8. Cabrera, M., M.-A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit, and J. M. Blackwell. 1995. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1259-1264.
9. Chen, G., R. Wilson, S. H. Wang, H. Z. Zheng, J. J. Walker, and J. H. McKillop. 1996. Tumour necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol. 103:154-159.
10. Chow, J. M., M. L. Yonekura, G. A. Richwald, S. Greenland, R. L. Sweet, and J. Schachter. 1990. The association between Chlamydia trachomatis and extopic pregnancy. A matched-pair, case-control study. JAMA 263:3164-3167.
11. Chow, W. H., J. R. Daling, W. Cates, and R. S. Greenberg. 1987. Epidemiology of ectopic pregnancy. Epidemiol. Rev. 9:70-94.
12. Conway, D. J., M. J. Holland, A. E. Campbell, R. L. Bailey, P. Krausa, R. W. Peeling, H. C. Whittle, and D. C. W. Mabey. 1996. HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population. J. Infect. Dis. 174:643-646.
13. D'Alfonso, S., and P. M. Richiardi. 1994. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150-154.
14. Darville, T., K. K. Laffoon, L. R. Kishen, and R. G. Rank. 1995. Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect. Immun. 63:4675-4681.
15. 2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163-2168.
16. de Kossodo, S., B. Critico, and G. E. Grau. 1994. Modulation of the transcripts for tumor necrosis factor-α and its receptors in vivo. Eur. J. Immunol. 24:769-772.
17. Elias, J. A., R. C. Krol, B. Freundlich, and P. M. Sampson. 1988. Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J. Clin. Invest. 81:325 333.
18. Grayston, J. T., S.-P. Wang, L.-J. Yeh, and C.-C. Kuo. 1985. Importance of reinfection in the pathogenesis of trachoma. Rev. Infect. Dis. 7:717-725.
19. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465-475.
20. Holland, M. J., R. L. Bailey, L. J. Haves, H. C. Whittle, and D. C. W. Mabey. 1993. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J. Infect. Dis. 168:1528-1531.
21. Ingalls, R. R., P. A. Rice, N. Qureshi, K. Takayama, J. Shin Lin, and D. T. Golenbock. 1995. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 63:3125-3130.
22. Kirkwood, B. R. 1988. Essentials of medical statistics. Blackwell Scientific Publications, Oxford, United Kingdom.
23. Mabey, D. C. W., R. L. Bailey, and Y. J. F. Hutin. 1992. The epidemiology and pathogenesis of trachoma. Rev. Med. Microbiol. 3:112-119.
24. McGuire, W., A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511.
25. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
26. Piguet, P. F., M. A. Collart, G. E. Grau, A.-P. Sappino, and P. Vassalli. 1990. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245-247.
27. Pociot, F., L. Briant, C. V. Jongeneel, J. Mohig, H. G. Worsaae, M. Abbal., M. Thomsen, J. Nerup, and A. Cambon-Thomsen. 1993. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:224-231.
28. Sariban, E., K. Imamura, R. Leubbers, and D. Kufe. 1988. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J. Clin. Invest. 81:1506-1510.
29. Shemer-Avni, Y., D. Wallach, and I. Sarov. 1988. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect. Immun. 56:2503-2506.
30. Shemer-Avni, Y., D. Wallach, and I. Sarov. 1989. Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. Infect. Immun. 57:3484-3490.
31. Taylor, H. R., S. L. Johnson, J. Schachter, H. D. Caldwell, and R. A. Prendergast. 1987. Pathogenesis of trachoma: the stimulus for inflammation. J. Immunol. 138:3023-3027.
32. Taylor, H. R., J. A. Siler, H. A. Mkocha, B. Munoz, and S. West. 1992. The natural history of endemic trachoma: a longitudinal study. Am. J. Trop. Med. Hyg. 46:552-559.
33. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
34. Williams, D. M., L. F. Bonewald, G. D. Roodman, G. I. Byrne, D. M. Magee, and J. Schachter. 1989. Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect. Immun. 57:1351-1355.
35. Williams, D. M., D. M. Magee, L. F. Bonewald, J. G. Smith, C. A. Bleicker, G. I. Byrne, and J. Schachter. 1990. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect. Immun. 58: 1572-1576.
36. Wilson, A. G., F. S. di Giovine, A. I. F. Blakemore, and G. W. Duff. 1992. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1:353.
37. Wilson, A. G., J. A. Symons, T. L. McDowell, F. S. di Giovine, and G. W. Duff. 1994. Effects of a tumor necrosis factor (TNF-alpha) promoter base transition on transcriptional activity. Br. J. Rheumatol. 33(Suppl.):89.